Best Practice and Research: Clinical Haematology
| 短名 | Best. Pract. Res. Clin. Haematol. |
| Journal Impact | 2.21 |
| 国际分区 | HEMATOLOGY(Q3) |
| 期刊索引 | SCI Q4中科院 4 区 |
| ISSN | 1521-6926, 1532-1924 |
| h-index | 81 |
| 国内分区 | 医学(4区)医学血液学(4区) |
BEST PRACTICE & RESEARCH CLINICAL HEMATOLOGY 发表评论文章，将最新原创研究文章的结果整合到实用的、基于证据的评论文章中。这些文章旨在解决诊断、治疗和患者管理的关键临床问题。每个问题都遵循以问题为导向的方法，重点关注要解决的关键问题，明确定义已知和未知的内容，涵盖临床和实验室血液学实践和研究的范围。尽管邀请了大多数评论，但编辑欢迎潜在作者的建议。
期刊主页投稿网址| 涉及主题 | 医学生物内科学遗传学免疫学病理化学外科生物化学癌症研究肿瘤科细胞生物学疾病干细胞白血病基因移植骨髓 |
| 出版信息 | 出版商: Bailliere Tindall Ltd，出版周期: Quarterly，期刊类型: journal |
| 基本数据 | 创刊年份: 1999，原创研究文献占比: 97.62%，自引率:0.00%， Gold OA占比: 16.08% |
| 平均审稿周期 | 网友分享经验：>12周，或约稿 |
| 平均录用比例 | 网友分享经验：较易 |
期刊引文格式
这些示例是对学术期刊文章的引用，以及它们应该如何出现在您的参考文献中。
并非所有期刊都按卷和期组织其已发表的文章，因此这些字段是可选的。有些电子期刊不提供页面范围，而是列出文章标识符。在这种情况下，使用文章标识符而不是页面范围是安全的。
只有1位作者的期刊
有2位作者的期刊
有3位作者的期刊
有5位以上作者的期刊
书籍引用格式
以下是创作和编辑的书籍的参考文献的示例。
学位论文引用格式
网页引用格式
这些示例是对网页的引用，以及它们应该如何出现在您的参考文献中。
专利引用格式
最新文章
From clones to immunopeptidomes: new developments in the characterization of permissive HLA-DP mismatches in hematopoietic cell transplantation
2024-9-1
Relevance of donor-specific HLA antibodies in hematopoietic cell transplantation
2024-9-1
Deciphering the role of the major histocompatibility complex, the intestinal microbiome and metabolites in the pathogenesis of acute graft-versus-host disease
2024-7-26
HLA Structure and Function in Hematopoietic-Cell Transplantation
2024-7-1
Allogeneic “Off-the-Shelf” CAR T Cells: Challenges and Advances
2024-7-1
Cytomegalovirus in haematopoietic cell transplantation - The troll is still there.
2024-7-1
Interfering with KIR and NKG2A immune checkpoint axes to unleash NK cell immunotherapy
2024-7-1
The collaborative biobank (CoBi): Donor and recipient samples & data to facilitate future research on hematopoietic cell transplantation
2024-6-1
Celebrating the registration of 9.000 patients treated with CAR T cells in the EBMT registry: Collection of real-world data in the context of hematopoietic cellular therapies
2024-6-1
Shape of the Art: TCR-repertoire after allogeneic Hematopoietic Cell Transplantation
2024-6-1
The most frequent HLA alleles around the world: A fundamental synopsis
2024-6-1
Corrigendum to “HIV-associated lymphoma” [Best Pract Res Clin Haematol 25 (2012) 101–117]
2024-6-1
Minor Histocompatibility Antigens to Predict, Monitor or Manipulate GvL and GvHD after Allogeneic Hematopoietic Cell Transplantation
2024-6-1
Editorial Board
2024-6-1
HLA typing: A review of methodologies and clinical impact on Haematopoietic Cell Transplantation
2024-6-1
The Role of Registries in Hematological Disorders
2024-6-1
Cytogenetics in haematology
2024-6-1
Cytogenetics and genomics in CML and other myeloproliferative neoplasms
2024-6-1
HLA-DM and HLA-DO interplay for the peptide editing of HLA class II in healthy tissues and leukemia
2024-6-1
Is HLA-E with its receptors an immune checkpoint or an antigenic determinant in allo-HCT?
2024-6-1
Registries and observational Databases in Haematology
2024-6-1
Corrigendum to “Designing and conducting a clinical trial in blood and marrow transplantation” [Best Pract Res Clin Haematol 36 (2023) 101471]
2024-3-1
Editorial Board
2024-3-1
Using real-world evidence in haematology
2024-3-1
Cytogenetics and genomics of acute myeloid leukemia
2024-3-1
Germline predisposition to myeloid neoplasms: Characteristics and management of high versus variable penetrance disorders
2024-3-1
Providing hematopoietic stem cell products from unrelated donors to the world: DKMS donor centers and DKMS registry
2024-3-1
Corrigendum to “Endpoint selection and evaluation in hematology studies” [Best Pract Res Clin Haematol 36 (2023) 101479]
2024-2-22
The landscape of cytogenetic and molecular genetic methods in diagnostics for hematologic neoplasia
2024-2-1
Cytogenetics and genomics of acute myeloid leukemia
2023-12-10
Cytogenetics and molecular genetics of myelodysplastic neoplasms
2023-12-1
Hodgkin Lymphoma: A disease shaped by the tumor micro- and macroenvironment
2023-12-1
When to use which molecular prognostic scoring system in the management of patients with MDS?
2023-12-1
The international cooperative Gaucher group (ICCG) Gaucher registry
2023-12-1
Asparaginase dosing for obese patients with acute lymphoblastic leukemia and factors that contribute to outcomes
2023-12-1
Editorial Board
2023-12-1
Cardiac surgery for radiation associated heart disease in Hodgkin lymphoma patients
2023-12-1
WHO, what, when, where, and why: New classification systems for acute myeloid leukemia and their impact on clinical practice
2023-12-1
The Australian Aplastic Anaemia and other Bone Marrow Failure Syndromes Registry
2023-12-1
Cytogenetics and genomics in pediatric acute lymphoblastic leukaemia
2023-12-1
The role of randomized controlled trials, registries, observational databases in evaluating new interventions
2023-12-1
Progress and challenges in the acute leukemia field
2023-12-1
Best practice & research clinical haematology: Screening for breast cancer in hodgkin lymphoma survivors
2023-11-26
The best GVHD prophylaxis: Or at least progress towards finding it
2023-10-20
Mechanisms of resistance to hypomethylating agents and BCL-2 inhibitors
2023-10-20
Cytogenomics of B-cell non-Hodgkin lymphomas: The “old” meets the “new”
2023-10-10
Preface of special edition “Biostatistics in clinical haematology”
2023-9-1
Graft versus Leukemia in 2023
2023-9-1
Donor lymphocyte infusion in Acute Myeloid Leukemia
2023-9-1
Describing and analyzing complex disease history in retrospective studies
2023-9-1
帮你贴心管理全部的文献
研飞ivySCI，高效的论文管理
投稿经验分享
分享我的经验，帮你走得更远